Why Envista Holdings (NVST) Is Back In The Spotlight
Envista Holdings (NVST) is gaining attention after reporting strong Q2 results, with 7.1% year-on-year revenue growth that exceeded analyst expectations. Despite recent short-term share price volatility, the company's Q2 performance is seen as a potential turning point after a longer period of underperformance. The stock is currently deemed 21% undervalued by a prominent narrative, with its valuation dependent on improved execution in growth, margins, and capital allocation, as well as navigating risks like China's procurement reforms and competition.
Dental Equipment & Technology Stocks Q2 Earnings Review: Envista (NYSE:NVST) Shines
Envista (NYSE:NVST) led the dental equipment and technology sector in Q2 earnings, reporting a 7.1% year-on-year revenue increase to $730.5 million, exceeding analysts' expectations. Despite strong financial performance from several companies, the sector's stock prices generally declined post-earnings, with Envista down 18.2% and Align Technology (NASDAQ:ALGN) showing the weakest performance against estimates. The article also touches upon market uncertainties, from AI's impact to geopolitical tensions, influencing investor sentiment.
Envista Holdings Price Target Cut to $26.00/Share From $29.00 by BMO Capital
BMO Capital has reduced its price target for Envista Holdings (NVST) shares to $26.00 from $29.00. This news was reported by Dow Jones, alongside a separate mention of Unity Software's Q4 financial results, where Unity exceeded revenue estimates but reported a quarterly loss.
BMO cuts Envista stock price target on China inventory headwind
BMO Capital lowered its price target for Envista Holdings Corp. (NVST) from $29 to $26, maintaining a Market Perform rating, due to an anticipated $10 million revenue headwind in Q3 2026 from a temporary distributor inventory drawdown in China. While most of these sales are expected to recover in Q4 2026, some may shift to early 2027. Despite the near-term challenges, Envista's 2026 guidance remains unchanged, and InvestingPro analysis suggests the stock is undervalued, with a PEG ratio of 0.48.
BMO cuts Envista stock price target on China inventory headwind By Investing.com
BMO Capital has reduced its price target for Envista Holdings Corp. (NYSE:NVST) to $26 from $29, maintaining a Market Perform rating, due to an expected $10 million revenue headwind in Q3 2026 from a temporary distributor inventory drawdown in China. Despite this near-term challenge, the company's 2026 guidance remains unchanged, and InvestingPro analysis suggests the stock is undervalued with a PEG ratio of 0.48. Other analysts have offered mixed outlooks, with UBS lowering its target, Stifel reiterating a Buy, BMO maintaining Market Perform, Mizuho reiterating Neutral, and JPMorgan upgrading to Overweight.
NVST5876122 Bond Profile: Coupon and Redemption
This article provides a detailed profile of the NVST5876122 bond issued by Envista Holdings Corporation. It covers key facts such as the issuer type, issue and maturity dates, face value, and minimum denomination. The bond has a fixed coupon rate of 1.75% paid semi-annually, with its redemption outstanding amount noted as $500.25 million USD.
Envista Holdings Corporation (NVST) Stock Price, News, Quote & History
This Yahoo Finance page provides a detailed overview of Envista Holdings Corporation (NVST), including its current stock price, recent news, historical data, and financial performance. It covers key metrics like market cap, P/E ratio, earnings, and analyst ratings, alongside a company profile and performance compared to the S&P 500. The article also lists the company's product segments and brands.
Stifel reiterates Buy on Envista stock, keeps $31 price target By Investing.com
Stifel maintained its Buy rating and $31 price target on Envista Holdings Corp. following the company's 2026 Investor Day. The company revised its medium-term financial objectives upward, with both its Equipment and Consumables divisions gaining market share. Envista has also seen recent leadership changes and an upgrade from JPMorgan, while BMO Capital and Mizuho reiterated their Market Perform and Neutral ratings, respectively.
Stifel reiterates Buy on Envista stock, keeps $31 price target
Stifel maintained its Buy rating and $31.00 price target for Envista Holdings Corp. (NYSE:NVST) after the company's 2026 Investor Day, noting its undervaluation and upward revised medium-term financial objectives. Envista has also seen a recent upgrade from JPMorgan and leadership changes, including Paul Keel's appointment as Board Chair with a revised compensation package.
Envista Holdings Unveils Strategic Vision at 2026 Investor Day on September 17
Envista Holdings Corporation held its 2026 Investor Day on September 17, 2026, where its executive leadership presented the company's strategic plans, growth initiatives, innovation priorities, and long-term financial goals. The event details were disclosed via a Form 8-K filing under Item 7.01 Regulation FD, ensuring fair disclosure of material nonpublic information. Presentation materials are available on the company's official website for investors.
Envista to Host 2026 Investor Day Outlining Strategy and Long-Term Objectives
Envista Holdings Corporation (NVST) is set to host an Investor Day on September 17, 2026, where its executive leadership will present the company's strategy, growth initiatives, innovation priorities, and long-term financial objectives. The presentation aims to guide investor expectations and will be available on Envista’s website following the event. This information is based on an original SEC Filing (8-K).
Envista launches Kerr dental consumables in India amid broader Asian expansion
Envista Holdings Corp. has launched Kerr consumables in India, marking the country as a strategic growth market due to increasing oral health awareness and demand for restorative treatments. This launch follows the opening of a new manufacturing facility in Suzhou, China, indicating Envista's broader focus on Asian expansion and increased regional production. The company plans to strengthen its presence in India through increased engagement with clinicians and educational initiatives.
Mizuho reiterates Envista stock rating ahead of investor day By Investing.com
Mizuho has reiterated a "Neutral" rating and a $29.00 price target for Envista Holdings Corp. ahead of its investor day on September 17. The firm noted Envista's outperformance in sales growth and financial health, and anticipates a refresh of its medium-term guidance and a focus on margin expansion. This follows strong Q2 2026 results and a recent upgrade by JPMorgan.
BMO reiterates Envista stock rating ahead of investor day By Investing.com
BMO Capital has reiterated its Market Perform rating for Envista Holdings Corp. (NYSE:NVST) with a $29.00 price target, ahead of the company's upcoming investor day. While Envista's stock is currently trading below this target, InvestingPro data suggests it may be undervalued with a Fair Value of $32.30. The firm is looking for management to present a more durable growth and margin algorithm, as well as potentially raised targets for 2025, which would be a positive catalyst.
Envista Announces Participation in Baird 2026 Global Healthcare Conference
Envista Holdings Corporation announced its participation in the Baird 2026 Global Healthcare Conference. The company will hold a fireside chat on September 15, 2026, which will be accessible via a live audio webcast and archived replay on its investor relations website. Envista, a global leader in the dental industry, aims to partner with dental professionals to improve patients' lives through its portfolio of technologies, consumables, and services.
BMO reiterates Envista stock rating ahead of investor day By Investing.com
BMO Capital reiterated a Market Perform rating on Envista Holdings Corp. (NYSE:NVST) with a $29.00 price target, noting that the upcoming investor day will be crucial for management to demonstrate improved growth and margin strategies. While Envista has shown solid revenue growth and analyst upgrades, BMO believes much of this is already reflected in expectations and valuation. This comes as JPMorgan recently upgraded Envista to Overweight, and the company reported strong Q2 2026 results.
Mizuho reiterates Envista stock rating ahead of investor day By Investing.com
Mizuho has reiterated a Neutral rating and $29.00 price target for Envista Holdings Corp. (NYSE:NVST) prior to the company's upcoming investor day. This target is below InvestingPro's Fair Value of $32.30, suggesting potential undervaluation, and the company has shown strong performance with a 21.7% year-to-date return and 11.89% revenue growth in the last twelve months. Analysts have revised earnings upwards, and the company maintains a "GOOD" financial health score, with margin expansion expected to be a key focus at the investor day.
Envista Holdings stock rises on JPMorgan upgrade
Envista Holdings Corp. (NYSE:NVST) shares rose 2.3% in premarket trading after JPMorgan upgraded the stock from Neutral to Overweight, raising its price target to $32.00 from $29.00. The upgrade precedes the company's September 17th Investor Day, with analysts citing improved execution and strengthening fundamentals. JPMorgan anticipates Envista will present a higher medium-term core growth framework and sustain mid-single-digit underlying growth.
JPMorgan upgrades Envista stock rating on improved execution By Investing.com
JPMorgan upgraded Envista Holdings Corp. (NVST) from Neutral to Overweight and raised its price target, citing improved execution, a more durable organic growth algorithm, and an undervalued stock. The upgrade comes ahead of Envista's Investor Day, where JPMorgan expects management to present a higher medium-term core growth framework. The firm noted Envista's ability to sustain mid-single-digit underlying growth despite macro uncertainties and highlighted the stock's strong performance and attractive valuation.
Envista Holdings stock rises on JPMorgan upgrade By Investing.com
Envista Holdings Corp. (NVST) shares rose 2.3% in premarket trading after JPMorgan upgraded the stock from Neutral to Overweight, increasing its price target to $32.00 from $29.00. The upgrade reflects JPMorgan's belief in the company's improved execution and more durable organic growth algorithm, especially ahead of its September 17th Investor Day. The analyst anticipates a medium-term core growth framework slightly above previous estimates, driven by consistent performance in faster-growing segments like implants and clear aligners.
Envista Holdings Shares Rise After JPMorgan Upgrade
Envista Holdings shares gained 2.3% in premarket trading following an upgrade from JPMorgan to Overweight from Neutral, with a price target increase to $32 from $29. The upgrade comes ahead of Envista's Investor Day on September 17, as JPMorgan anticipates improved execution, a more durable organic growth model, and an undervalued stock given its strengthening fundamentals. The analyst expects management to project a medium-term core growth framework modestly above previous estimates, noting the company's resilient performance despite macroeconomic challenges in the dental market.
Envista Holdings stock rises on JPMorgan upgrade By Investing.com
Envista Holdings Corp. (NYSE:NVST) shares rose 2.3% in premarket trading after JPMorgan upgraded the stock from Neutral to Overweight, setting a new price target of $32.00. The upgrade, ahead of the company’s September 17th Investor Day, reflects improved execution and a more durable organic growth algorithm. JPMorgan believes Envista merits a higher valuation given its strengthening fundamentals and resilient performance despite macroeconomic uncertainties.
JPMorgan upgrades Envista stock rating on improved execution
JPMorgan has upgraded Envista Holdings Corp. (NYSE:NVST) from Neutral to Overweight and raised its price target to $32.00, citing improved execution and a more durable organic growth algorithm ahead of the company's Investor Day. The firm anticipates Envista will present a medium-term core growth framework slightly above its previous range, driven by share gains in implants and clear aligners. This upgrade follows strong Q2 2026 financial results where Envista surpassed expectations and raised its full-year outlook, alongside a significant leadership change with Paul Keel appointed as Chair of the Board.
Envista Holdings CFO Eric D. Hammes Withholds 10,885 Shares for RSU Tax Payment
Envista Holdings CFO Eric D. Hammes withheld 10,885 shares of common stock on August 25, 2026, to cover tax obligations related to the vesting of Restricted Stock Units. The shares were withheld at a price of $27.47 each, and this transaction was reported in a Form 4 filed on August 27, 2026. After the withholding, Hammes directly beneficially owned 99,913 shares of Envista Holdings common stock.
Envista (NYSE: NVST) orthodontics chief withholds shares for RSU taxes
Veronica Acurio, President of Orthodontics at Envista Holdings Corp (NVST), withheld 7,710 shares valued at $27.47 each to cover tax obligations arising from the vesting of stock-settled Restricted Stock Units (RSUs) on August 25, 2026. Following this transaction, Acurio directly holds 48,806 shares of Envista common stock. This insider transaction was reported via a Form 4 filing and was not conducted under a Rule 10b5-1 trading plan.
Envista (NYSE: NVST) Diagnostics president uses shares to pay taxes
Envista Holdings Corp (NVST) President of Diagnostics, Robert Befidi, used 5,147 shares of common stock to cover tax withholding obligations. The shares, valued at $27.47 each, were withheld on August 25, 2026, upon the vesting of stock-settled Restricted Stock Units. After this transaction, Befidi directly holds 45,785 shares of Envista common stock.
Envista Holdings (NYSE:NVST): A Decent Value Play with Undervaluation and Growth Potential
Envista Holdings (NYSE:NVST) is identified as a decent value play due to its strong valuation score, particularly when compared to its industry and the broader market. Despite acceptable but not spectacular profitability and manageable financial health, the company shows potential for accelerated growth in EPS and revenue, making it attractive for value investors looking for future growth catalysts. The article highlights that NVST also appears on free cash flow and high EPS growth screens, reinforcing its fundamental strength.
Envista (NVST): Buy, Sell, or Hold Post Q2 Earnings?
Envista's shares have underperformed the S&P 500, losing 7.6% over the past six months. Analysts are cautious due to the company's disappointing long-term revenue growth, declining EPS, and negative return on invested capital (ROIC). Despite the stock trading at 17.3x forward P/E, the analysis suggests better investment opportunities exist elsewhere.
Envista Holdings SVP Mischa Reis Sells 8,000 Shares Under Rule 10b5-1 Trading Plan
Mischa Reis, Senior Vice President of Strategy and Business Development at Envista Holdings Corp (NYSE:NVST), sold 8,000 shares of company stock on August 20, 2026. This transaction was executed under a pre-established Rule 10b5-1 trading plan, with the shares sold at $27.50 each. Following the sale, Reis directly holds 27,321 shares of Envista common stock.
Envista (NYSE: NVST) SVP sells 8,000 shares under 10b5-1 plan
Mischa Reis, SVP, Strategy & Business Development at Envista Holdings Corp (NYSE: NVST), sold 8,000 shares of company common stock on August 20, 2026, at a price of $27.50 per share. This transaction was executed under a pre-established Rule 10b5-1 trading plan. Following the sale, Reis directly holds 27,321 shares of Envista common stock.
Envista Holdings Corp (NVST) News, Articles, Events & Latest Updates
This article provides recent news and updates for Envista Holdings Corp (NVST), highlighting its upgrade to a Zacks Rank #1 (Strong Buy) due to growing optimism about its earnings prospects. It also features comparisons with other stocks, discusses option market movements, and mentions other companies alongside Envista in stock lists. The news covers Envista's potential for sustained guidance boost and expanding margins despite challenges like China pricing and tariffs.
Envista (NYSE: NVST) officer sets NYSE sale plan for 8,000 shares
An officer at Envista Holdings Corp (NVST), Mischa Reis, has filed a Form 144 notice indicating an intent to sell 8,000 shares of common stock on the NYSE. The planned sale, with an aggregate market value of $220,000, is scheduled for August 20, 2026, and will be executed through Fidelity Brokerage Services LLC. The shares were acquired through various restricted stock vesting events between 2020 and 2025 as compensation.
Envista Holdings CFO Eric D. Hammes Awarded 47,970 Performance Share Units
Envista Holdings Corp's CFO, Eric D. Hammes, was granted 47,970 Performance Share Units (PSUs) on August 18, 2026. These PSUs, awarded at a price of $0, will vest over a four-year period based on achieving specific performance targets. The potential payout for Hammes ranges from 75% to 125% of the target units, depending on performance results.
Envista (NYSE: NVST) CEO adds to stake with fresh stock awards
Envista Holdings Corp (NYSE: NVST) CEO Paul A. Keel received new stock awards on August 18, 2026, increasing his stake in the company. The awards include 179,730 Restricted Stock Units (RSUs) that vest ratably over four years and 159,900 Performance Share Units (PSUs) tied to four-year performance goals. Following these grants, Keel's direct common stock holdings now total 551,304 shares.
Zacks.com featured highlights Envista , Reliance, The Ensign, The Hanover Insurance and Lenovo
This Zacks.com article highlights four stocks – Envista (NVST), Reliance, Inc. (RS), The Hanover Insurance Group (THG), and Lenovo Group (LNVGY) – that are trading near their 52-week highs and are believed to have further upside potential. The article explains that while a 52-week high can raise concerns about overvaluation, these specific stocks are supported by strong fundamentals and market momentum. It provides detailed reasons for the continued positive outlook for Reliance, The Hanover Insurance Group, and Lenovo, including robust earnings, strategic initiatives, and growing market demand.
Envista (NYSE: NVST) insider trading activity disclosed
Envista Holdings Corp (NVST) Chief Financial Officer Eric D. Hammes reported a transaction involving 47,970 Performance Share Units (PSUs). These PSUs will vest over a four-year period based on performance measures, with the potential to earn 75-125% of the reported amount. This information was disclosed in a Form 4 filing with the SEC.
Form 8K Envista Holdings Corp For: 19 August By Investing.com
This article reports on the filing of a Form 8K by Envista Holdings Corp for August 19th. The content is brief, primarily serving as an announcement of the filing and indicating that more details would be available in the form itself. It also provides current stock market data and trending news, though these are not directly related to the Form 8K announcement.
Form 8K Envista Holdings Corp For: 19 August By Investing.com
This article announces that Envista Holdings Corp filed a Form 8K on August 19. It is a brief report from Investing.com, providing basic information about the filing. The article provides no further details about the content of the Form 8K.
Envista Holdings appoints Paul Keel as board chair, announces executive awards
Envista Holdings has appointed Paul Keel, its President and CEO, as the new Chair of the Board, succeeding Scott Huennekens who will now serve as Lead Independent Director. Concurrently, the company announced significant compensation changes for Keel, including a substantial salary increase and a $10 million equity award, alongside a $1.5 million equity award for CFO Eric Hammes, reflecting strong financial performance with shares up 28% year-to-date. These executive appointments and awards follow impressive Q2 2026 financial results that exceeded Wall Street expectations.
Envista Holdings (NVST) CAO details options, RSUs and phantom shares in Form 3
Envista Holdings Corp.'s Chief Administrative Officer, Thomas Coree K., has filed a Form 3 detailing his initial beneficial ownership of the company's equity. This includes various employee stock options, restricted stock units (RSUs) with vesting schedules, and notional phantom shares linked to Envista stock through deferred contribution programs. The filing provides a breakdown of these holdings, their exercise prices, expiration dates, and vesting conditions, offering insight into Coree K.'s equity stake in NVST.
Zacks.com featured highlights include Envista, Sanmina, TAL Education and Avient
Zacks.com highlights four "PEG-Driven Value Stocks" for strong returns: Envista Corp. (NVST), Sanmina Corp. (SANM), TAL Education Group (TAL), and Avient Corp. (AVNT). The article explains the PEG ratio as a better indicator for value investing than P/E alone, helping investors identify stocks with potential for future earnings growth while avoiding "value traps." Each company is briefly described with its Zacks Rank, Value Score, and expected growth rate.
First Trust Advisors LP Has $1.39 Million Stock Holdings in Envista Holdings Corporation $NVST
First Trust Advisors LP significantly reduced its stake in Envista Holdings Corporation (NYSE:NVST) by 79.5% in the first quarter, now holding 54,922 shares valued at $1.39 million. Envista reported strong quarterly earnings, beating analyst estimates with an EPS of $0.41 and a 7.1% revenue increase, and provided optimistic fiscal 2026 EPS guidance. Despite this, analyst sentiment remains cautious, with a consensus "Hold" rating and an average price target of $29.31.
Analysts Conflicted on These Healthcare Names: Protagonist Therapeutics (PTGX), Qiagen (QGEN) and Envista Holdings (NVST)
Barclays analysts have offered varied ratings for several healthcare companies. Etzer Darout maintained a Buy rating for Protagonist Therapeutics (PTGX) with a $153.00 price target, while Luke Sergott gave Qiagen (QGEN) a Hold rating with a $38.00 target. Glen Santangelo maintained a Buy rating for Envista Holdings (NVST) with a $32.00 price target, noting a moderate buy consensus for the stock.
Earnings call transcript: Envista tops Q2 2026 estimates and raises outlook
Envista Holdings (NVST) exceeded Wall Street expectations for Q2 2026, reporting adjusted earnings of $0.41 per share on revenue of $730.5 million, surpassing analyst estimates. The company raised its full-year 2026 guidance, citing strong performance across its dental portfolio, increased margins, and robust free cash flow. Management highlighted new product innovation, market share gains, and productivity improvements as key drivers offsetting macroeconomic pressures and pricing changes in China.
Dental company Envista reports 5% core sales growth in Q2
Envista Holdings Corporation (NYSE: NVST) reported strong second-quarter 2026 results, achieving 5.0% core sales growth and a 58% year-over-year increase in adjusted diluted EPS. The company raised its full-year 2026 guidance for core sales growth, adjusted EBITDA growth, and adjusted EPS, reflecting confidence in its continued performance. Envista also generated significant operating and free cash flow and repurchased shares during the quarter.
NVST Q2 Deep Dive: Margin Expansion and Product Launches Amid China Market Shifts
Envista Holdings (NYSE:NVST) reported better-than-expected Q2 CY2026 results, with revenue up 7.1% year-on-year to $730.5 million and adjusted EPS beating estimates by 22.1%. The company's performance was driven by balanced growth across geographies, new product launches in endodontics and orthodontics, and margin expansion due to operational efficiencies. Envista is navigating China's volume-based procurement (VBP) reforms
Envista Holdings Corp 2026: Revenue $730.5M, EPS $0.33— 10-Q Summary
Envista Holdings Corp (NVST) reported strong results for the 2026 quarter, with revenue reaching $730.5M and diluted EPS of $0.33, indicating significant year-over-year growth. Net income more than doubled to $53.7M. The company experienced broad-based revenue growth, driven by volume and pricing increases, particularly in developed markets and within its Specialty and Equipment segments.
Envista Holdings Corp (NVST) (Q2 2026) Earnings Call Highlights: Strong Core Growth and Raised ...
Envista Holdings Corp (NVST) reported strong Q2 2026 results, with core sales up 5%, adjusted EBITDA increasing 28%, and adjusted EPS growing 58%. The company raised its full-year 2026 guidance due to broad-based growth across segments and geographies. However, anticipated headwinds include a Q4 slowdown due to fewer selling days, declines in the Brackets & Wires business, and significant price compression from China's Volume-Based Procurement initiatives.
Earnings call transcript: Envista tops Q2 2026 estimates and raises outlook
Envista Holdings reported strong Q2 2026 results, surpassing Wall Street expectations with adjusted EPS of $0.41 and revenue of $730.5 million. The company's stock rose significantly, driven by improved margins, higher cash flow, and a raised full-year outlook. Management attributed the success to broad-based strength across its dental portfolio, new product innovation, share gains, and productivity improvements, despite macro pressures and China pricing changes.
Envista Holdings (NYSE: NVST) doubles Q2 2026 profit on higher sales and cash flow
Envista Holdings (NYSE: NVST) reported a strong Q2 2026, doubling its net profit to $53.7 million compared to the previous year, driven by a 7.1% increase in sales to $730.5 million. The company's gross margin improved to 55.7% and operating margin to 11.0%, boosted by higher volumes, pricing strategies, and a $12.6 million tariff refund. For the first half of 2026, sales reached $1.44 billion, with net income exceeding $92.4 million, and the company generated $115.9 million in operating cash flow, which was used for acquisitions and share repurchases.
